These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 35099994)

  • 21. Reply to Rappaport
    Dutt T; Simcox D; Downey C; McLenaghan D; King C; Gautam M; Lane S; Burhan H
    Am J Respir Crit Care Med; 2020 Dec; 202(12):1733-1734. PubMed ID: 32931711
    [No Abstract]   [Full Text] [Related]  

  • 22. The effect of anticoagulation on clinical outcomes in novel Coronavirus (COVID-19) pneumonia in a U.S. cohort.
    Lynn L; Reyes JA; Hawkins K; Panda A; Linville L; Aldhahri W; Kango G; Shah S; Ayanian S; Teufel K
    Thromb Res; 2021 Jan; 197():65-68. PubMed ID: 33186849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients: comment.
    Roncon L; Zuin M; Rigatelli G
    Intern Emerg Med; 2021 Mar; 16(2):517-518. PubMed ID: 32378044
    [No Abstract]   [Full Text] [Related]  

  • 24. Extended Duration Enoxaparin Decreases the Rate of Venous Thromboembolic Events after Radical Cystectomy Compared to Inpatient Only Subcutaneous Heparin.
    Pariser JJ; Pearce SM; Anderson BB; Packiam VT; Prachand VN; Smith ND; Steinberg GD
    J Urol; 2017 Feb; 197(2):302-307. PubMed ID: 27569434
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The management of venous thromboembolism in hospitalized patients with COVID-19.
    Spyropoulos AC
    Blood Adv; 2020 Aug; 4(16):4028. PubMed ID: 32841342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A matter of time: duration and choice of venous thromboprophylaxis in patients diagnosed with COVID-19.
    Kumar P; Mediwake R; Rhead C
    Br J Hosp Med (Lond); 2020 May; 81(5):1-2. PubMed ID: 32468942
    [No Abstract]   [Full Text] [Related]  

  • 27. Venous Thromboembolism and Major Bleeding in Patients With Coronavirus Disease 2019 (COVID-19): A Nationwide, Population-Based Cohort Study.
    Dalager-Pedersen M; Lund LC; Mariager T; Winther R; Hellfritzsch M; Larsen TB; Thomsen RW; Johansen NB; Søgaard OS; Nielsen SL; Omland LH; Lundbo LF; Israelsen SB; Harboe ZB; Pottegård A; Nielsen H; Bodilsen J
    Clin Infect Dis; 2021 Dec; 73(12):2283-2293. PubMed ID: 33400771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thrombin generation in patients with COVID-19 with and without thromboprophylaxis.
    Campello E; Bulato C; Spiezia L; Boscolo A; Poletto F; Cola M; Gavasso S; Simion C; Radu CM; Cattelan A; Tiberio I; Vettor R; Navalesi P; Simioni P
    Clin Chem Lab Med; 2021 Jun; 59(7):1323-1330. PubMed ID: 33544518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Colchicine as an adjunct to heparin for prophylaxis of venous thromboembolism in patients with COVID-19.
    Kow CS; Hasan SS
    Rheumatol Int; 2021 Mar; 41(3):677-678. PubMed ID: 33388902
    [No Abstract]   [Full Text] [Related]  

  • 30. Trends in Venous Thromboembolism Anticoagulation in Patients Hospitalized With COVID-19.
    Vaughn VM; Yost M; Abshire C; Flanders SA; Paje D; Grant P; Kaatz S; Kim T; Barnes GD
    JAMA Netw Open; 2021 Jun; 4(6):e2111788. PubMed ID: 34115129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atorvastatin versus placebo in patients with covid-19 in intensive care: randomized controlled trial.
    INSPIRATION-S Investigators
    BMJ; 2022 Jan; 376():e068407. PubMed ID: 34996756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Venous Thromboembolism in Hospitalized COVID-19 Patients Treated in a Single Academic Center in Mexico: A Case Series Study.
    Ontiveros N; Becerril-Gaitan A; Llausas-Villarreal A; Gonzalez-Urquijo M; Paredes-Vazquez JG; Martínez-Resendez MF; Fabiani MA
    Vasc Endovascular Surg; 2022 Feb; 56(2):144-150. PubMed ID: 34666570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients: comment.
    Allione A; Giamello JD; Paglietta G; Bernardi S; Cavalot G
    Intern Emerg Med; 2021 Mar; 16(2):519-520. PubMed ID: 32440985
    [No Abstract]   [Full Text] [Related]  

  • 34. Weight-adjusted versus fixed dose heparin thromboprophylaxis in hospitalized obese patients: A systematic review and meta-analysis.
    Ceccato D; Di Vincenzo A; Pagano C; Pesavento R; Prandoni P; Vettor R
    Eur J Intern Med; 2021 Jun; 88():73-80. PubMed ID: 33888393
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Venous Thromboembolism in COVID-19: Towards an Ideal Approach to Thromboprophylaxis, Screening, and Treatment.
    Aryal MR; Gosain R; Donato A; Pathak R; Bhatt VR; Katel A; Kouides P
    Curr Cardiol Rep; 2020 Jun; 22(7):52. PubMed ID: 32529517
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PERTinent new insights into venous thromboembolism risk and management in hospitalized patients with COVID-19.
    Han H; Barnes GD
    Vasc Med; 2021 Aug; 26(4):434-436. PubMed ID: 34014133
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical outcome with different doses of low-molecular-weight heparin in patients hospitalized for COVID-19.
    Mennuni MG; Renda G; Grisafi L; Rognoni A; Colombo C; Lio V; Foglietta M; Petrilli I; Pirisi M; Spinoni E; Azzolina D; Hayden E; Aimaretti G; Avanzi GC; Bellan M; Cantaluppi V; Capponi A; Castello LM; D'Ardes D; Corte FD; Gallina S; Krengli M; Malerba M; Pierdomenico SD; Savoia P; Zeppegno P; Sainaghi PP; Cipollone F; Patti G;
    J Thromb Thrombolysis; 2021 Oct; 52(3):782-790. PubMed ID: 33649979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Finding the Optimal Thromboprophylaxis Dose in Patients With COVID-19.
    Al-Samkari H
    JAMA; 2021 Apr; 325(16):1613-1615. PubMed ID: 33734290
    [No Abstract]   [Full Text] [Related]  

  • 39. Significant Major Bleeding in Hospitalized Patients with COVID-19 Receiving Thromboprophylaxis.
    Mai V; Mainbourg S; Tan BK; Lega JC; Provencher S
    Thromb Haemost; 2021 Dec; 121(12):1670-1673. PubMed ID: 33831962
    [No Abstract]   [Full Text] [Related]  

  • 40. Spontaneous psoas haematoma from enhanced venous thromboembolism (VTE) prophylaxis for COVID-19 infection.
    Das AK; Price T; Woodcock-Shaw J; Zava NK
    Age Ageing; 2021 Nov; 50(6):1888. PubMed ID: 34628488
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.